GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » Price-to-Owner-Earnings

iRadimed (iRadimed) Price-to-Owner-Earnings : 65.86 (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is iRadimed Price-to-Owner-Earnings?

As of today (2024-05-16), iRadimed's share price is $42.15. iRadimed's Owner Earnings per Share (TTM) ended in Mar. 2024 was $0.64. It's Price-to-Owner-Earnings for today is 65.86.


The historical rank and industry rank for iRadimed's Price-to-Owner-Earnings or its related term are showing as below:

IRMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 25.69   Med: 64.4   Max: 3126
Current: 66.32

During the past 12 years, the highest Price-to-Owner-Earnings of iRadimed was 3126.00. The lowest was 25.69. And the median was 64.40.


IRMD's Price-to-Owner-Earnings is ranked worse than
75.81% of 277 companies
in the Medical Devices & Instruments industry
Industry Median: 33.93 vs IRMD: 66.32

As of today (2024-05-16), iRadimed's share price is $42.15. iRadimed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $1.41. Therefore, iRadimed's PE Ratio for today is 29.89.

As of today (2024-05-16), iRadimed's share price is $42.15. iRadimed's EPS without NRI for the trailing twelve months (TTM) ended in was $1.44. Therefore, iRadimed's PE Ratio without NRI for today is 29.27.

During the past 12 years, iRadimed's highest PE Ratio without NRI was 294.10. The lowest was 12.60. And the median was 40.02.


iRadimed Price-to-Owner-Earnings Historical Data

The historical data trend for iRadimed's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Price-to-Owner-Earnings Chart

iRadimed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.35 223.53 63.04 45.19 68.70

iRadimed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.54 56.10 69.76 68.70 68.95

Competitive Comparison of iRadimed's Price-to-Owner-Earnings

For the Medical Devices subindustry, iRadimed's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where iRadimed's Price-to-Owner-Earnings falls into.



iRadimed Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

iRadimed's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=42.15/0.64
=65.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRadimed  (NAS:IRMD) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


iRadimed Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of iRadimed's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed (iRadimed) Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.
Executives
Roger E. Susi director, 10 percent owner, officer: CEO, President, Chairman C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Anthony Vuoto director
Monty K Allen director
Hilda Frederique Scharen-guivel director 440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
John Glenn officer: Chief Financial Officer 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Christopher K. Scott officer: CHIEF FINANCIAL OFFICER & SECR C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson officer: Exec. VP. Sales & Marketing 4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi officer: VP MANUFACTURING C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman officer: CONTROLLER C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell director, officer: Chief Exec Officer & Director 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey officer: VP OF REG AND QUAL ASSURANCE C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery officer: Chief Operating Officer IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy director INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708

iRadimed (iRadimed) Headlines

From GuruFocus

RESOURCE CONSULTING GROUP INC Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-19-2023

IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022

By Stock market mentor Stock market mentor 01-18-2023

IRADIMED Names John F. Glenn Chief Financial Officer

By PurpleRose PurpleRose 07-15-2022

IRADIMED Names John F. Glenn Chief Financial Officer

By GuruFocusNews GuruFocusNews 06-15-2022

IRADIMED CORPORATION Announces Executive Transition

By GuruFocusNews GuruFocusNews 04-28-2022

IRADIMED Names John F. Glenn Chief Financial Officer

By GuruFocusNews GuruFocusNews 06-05-2022

RESOURCE CONSULTING GROUP INC Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-11-2022